SCORE: A multisite randomised controlled trial evaluating shared care for colorectal cancer survivors.

Michael Jefford; Jon D Emery; Andrew James Martin; Richard De Abreu Lourenco; Karolina Lisy; Mustafa Abdi Mohamed; Dorothy King; Niall C Tebbutt; Margaret Lee; Ashkan Mehrnejad; Adele Burgess; Julie Marker; Renee Eggins; Joseph Carrello; Penelope Schofield

Conference Proceedings

SCORE: A multisite randomised controlled trial evaluating shared care for colorectal cancer survivors.

Michael Jefford, Jon D Emery, Andrew James Martin, Richard De Abreu Lourenco, Karolina Lisy, Mustafa Abdi Mohamed, Dorothy King, Niall C Tebbutt, Margaret Lee, Ashkan Mehrnejad, Adele Burgess, Julie Marker, Renee Eggins, Joseph Carrello, Penelope Schofield

JOURNAL OF CLINICAL ONCOLOGY | LIPPINCOTT WILLIAMS & WILKINS | Published : 2023

DOI: 10.1200/jco.2023.41.4_suppl.84

Abstract

84 Background: Colorectal cancer (CRC) survivorship is rising. Few studies have considered shared follow up (FU) care (SC) between oncologists and primary care providers (PCPs). SCORE is the first large RCT of SC for CRC survivors. Aim: to compare SC with usual care (UC) for CRC survivors. Primary objective: assess the effect of SC vs UC on the EORTC QLQ-C30 Global Health Status/Quality of Life (GHQ-QoL) scale to 12 months (mo). Secondary objectives: assess the effect of SC vs UC on QoL; pt perceptions of care; costs; clinical care processes (CEA tests, recurrences); and feasibility (recruitment, completion rate). Methods: Pts had stage I-III CRC, completed all treatments within 3 mo, spoke..

View full abstract